Bruhal Shah PhD

Bruhal Shah, Ph.D., is the director of the formulation at Experic. Dr. Shah oversees formulation and process development activities at Experic and provides scientific leadership to client projects. With more than 10 years of diverse research experience in the pharmaceutical and biopharmaceutical fields, Dr. Shah has managed early- to late-phase development of clinical trial materials (CTMs) and commercialization projects including the development of robust drug delivery systems with conventional and non-conventional technologies.

Dr. Shah’s focus is on pre-formulation, formulation/process development, and optimization using a quality-by-design (QbD) approach. He has specialized expertise in the development and manufacturing of oral formulations (solid and liquid) and semi-solid dosage forms. He has worked extensively on various technology platforms to improve the solubility of poorly water-soluble drugs.

Prior to joining Experic, Dr. Shah held R&D scientific roles for Cambrex (formerly Halo Pharmaceutical). Dr. Shah received his Ph.D. in pharmaceutics and drug design, and an MS in pharmacology and toxicology from Long Island University (Brooklyn, NY). He has primarily presented on topics of solubility improvement strategies for poorly soluble molecules, drug delivery approaches for pediatric formulation development, and design of experiments (DoE) approach during scale-up activities.